A series of 27 salicylanilide-based carbamates was prepared as a part of our ongoing search for new antituberculosis drugs. These compounds exhibited very good in vitro activity against Mycobacterium tuberculosis, Mycobacterium kansasii and Mycobacterium avium and, in particular, against five multidrug-resistant strains, with MIC values between 0.5-2 micromol/L. Moreover, they displayed moderate toxicity against intestinal cells with the selectivity index being up to 96. Furthermore, acid stability and a half-life of 43h at pH 7.4 were shown. Thus, these novel salicylanilide derivatives are drug candidates which should be seriously consider for further screening.

Department of Inorganic and Organic Chemistry Faculty of Pharmacy Charles University Heyrovského 1203 500 05 Hradec Králové Czech Republic

Citace poskytuje Crossref.org

Dibasic Derivatives of Phenylcarbamic Acid against Mycobacterial Strains: Old Drugs and New Tricks?

Synthesis and In Vitro Antimycobacterial Activity of Novel N-Arylpiperazines Containing an Ethane-1,2-diyl Connecting Chain

Antibacterial activity of salicylanilide 4-(trifluoromethyl)-benzoates

Antimycobacterial assessment of Salicylanilide benzoates including multidrug-resistant tuberculosis strains

Acetylcholinesterase-inhibiting activity of salicylanilide N-alkylcarbamates and their molecular docking

Antimycobacterial activity of salicylanilide benzenesulfonates

Investigating spectrum of biological activity of 4- and 5-chloro-2-hydroxy-N-[2-(arylamino)-1-alkyl-2-oxoethyl]benzamides

Investigating the spectrum of biological activity of ring-substituted salicylanilides and carbamoylphenylcarbamates